Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.96%126.7B | 12.21%489.01B | 18.23%130.61B | 9.91%123.51B | 12.65%123.71B | 7.81%111.18B | 20.55%435.79B | 18.28%110.47B | 15.14%112.37B | 26.43%109.81B |
Cost of revenue | 8.03%88.01B | 6.46%348.91B | 8.71%91.8B | 4.95%87.03B | 5.01%88.61B | 7.20%81.47B | 20.95%327.74B | 17.19%84.45B | 16.30%82.92B | 28.51%84.38B |
Gross profit | 30.20%38.69B | 29.67%140.1B | 49.11%38.81B | 23.86%36.48B | 38.02%35.1B | 9.52%29.72B | 19.36%108.04B | 21.97%26.03B | 12.00%29.45B | 19.98%25.43B |
Operating expense | 11.48%18.42B | 8.41%73.4B | 14.44%20.12B | 10.56%18.29B | 7.49%18.47B | 0.72%16.52B | 11.41%67.71B | 7.08%17.58B | 1.68%16.54B | 16.08%17.18B |
Staff costs | ---- | 11.26%11.27B | ---- | ---- | ---- | ---- | 1.72%10.13B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | 3.94%44.47B | ---- | ---- | ---- | ---- | 12.51%42.78B | ---- | ---- | ---- |
-Selling and marketing expense | ---- | 2.61%10.82B | ---- | ---- | ---- | ---- | 34.59%10.54B | ---- | ---- | ---- |
-General and administrative expense | ---- | 4.38%33.65B | ---- | ---- | ---- | ---- | 6.78%32.24B | ---- | ---- | ---- |
Research and development costs | ---- | 1.29%1.57B | ---- | ---- | ---- | ---- | -1.08%1.55B | ---- | ---- | ---- |
Depreciation and amortization | ---- | 19.98%1.34B | ---- | ---- | ---- | ---- | 18.98%1.12B | ---- | ---- | ---- |
-Depreciation | ---- | 19.98%1.34B | ---- | ---- | ---- | ---- | 18.98%1.12B | ---- | ---- | ---- |
Other operating expenses | ---- | 21.61%14.75B | ---- | ---- | ---- | ---- | 17.96%12.13B | ---- | ---- | ---- |
Operating profit | 53.65%20.27B | 65.38%66.7B | 121.26%18.69B | 40.91%18.19B | 101.58%16.63B | 22.97%13.19B | 35.60%40.33B | 71.67%8.45B | 28.74%12.91B | 29.00%8.25B |
Net non-operating interest income (expenses) | 51.04%1.97B | 202.03%6.09B | 97.81%1.98B | 145.28%1.38B | 317.84%1.43B | 1,073.87%1.3B | 1,209.74%2.02B | 2,080.43%1B | 2,852.63%561M | 1,700.00%342M |
Non-operating interest income | 48.89%2.02B | 181.46%6.3B | 92.06%2.03B | 131.49%1.43B | 273.87%1.49B | 711.98%1.36B | 481.56%2.24B | 927.18%1.06B | 710.53%616M | 416.88%398M |
Non-operating interest expense | -3.77%51M | -5.41%210M | -12.73%48M | -9.09%50M | 5.36%59M | -5.36%53M | -3.90%222M | -3.51%55M | -3.51%55M | -3.45%56M |
Net investment income | 15.36%353M | 171.50%1.11B | 437.78%484M | 1,635.29%261M | -39.33%54M | 24.90%306M | -53.16%407M | -76.44%90M | -108.63%-17M | 50.85%89M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 512M | 197M | 65M | 132M | 0 | 0 | ||||
Income from associates and other participating interests | 244.44%62M | 24.73%116M | 228.57%23M | 150.00%55M | -35.48%20M | -45.45%18M | -36.30%93M | -74.07%7M | -55.10%22M | 14.81%31M |
Special income (charges) | -1,100.00%-24M | -902.96%-2.04B | -3,322.22%-1.54B | -550.00%-91M | -706.00%-403M | 97.87%-2M | 17.81%-203M | 71.88%-45M | 83.13%-14M | 54.13%-50M |
Less:Other special charges | 1,100.00%24M | 62.71%96M | -20.48%-100M | 607.69%92M | 191.43%102M | -97.87%2M | -67.76%59M | -169.17%-83M | -84.34%13M | -58.82%35M |
Less:Write off | ---- | 1,247.22%1.94B | 1,181.25%1.64B | -200.00%-1M | ---- | ---- | 125.00%144M | 220.00%128M | --1M | ---- |
Other non-operating income (expenses) | -42.27%265M | 15.06%1.04B | -57.20%101M | -11.32%94M | 11.27%385M | 113.49%459M | -2.59%903M | 198.73%236M | -71.96%106M | 57.99%346M |
Income before tax | 53.22%23.41B | 68.11%73.21B | 103.35%19.8B | 47.56%20.02B | 101.10%18.12B | 35.95%15.28B | 37.87%43.55B | 84.20%9.74B | 28.14%13.57B | 36.23%9.01B |
Income tax | 35.03%5.67B | 80.14%18.11B | 146.28%4.74B | 54.75%5.16B | 71.73%4.01B | 70.83%4.2B | 17.29%10.05B | 75.14%1.92B | 11.01%3.34B | 18.53%2.34B |
Net income | 60.12%17.74B | 64.50%55.1B | 92.78%15.06B | 45.20%14.85B | 111.40%14.11B | 26.18%11.08B | 45.53%33.49B | 86.54%7.81B | 34.97%10.23B | 43.69%6.67B |
Net income continuous operations | 60.12%17.74B | 64.51%55.1B | 92.78%15.06B | 45.22%14.85B | 111.37%14.11B | 26.18%11.08B | 45.53%33.49B | 86.58%7.81B | 34.93%10.23B | 43.74%6.67B |
Noncontrolling interests | 96.15%102M | -250.27%-553M | -1,321.43%-684M | -38.64%81M | -103.85%-2M | -59.38%52M | -38.67%368M | -55.91%56M | -34.33%132M | -52.29%52M |
Net income attributable to the company | 59.97%17.63B | 68.00%55.65B | 103.00%15.75B | 46.29%14.77B | 113.09%14.11B | 27.45%11.02B | 47.79%33.13B | 91.04%7.76B | 36.87%10.1B | 46.00%6.62B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 59.97%17.63B | 68.00%55.65B | 103.00%15.75B | 46.29%14.77B | 113.09%14.11B | 27.45%11.02B | 47.79%33.13B | 91.04%7.76B | 36.87%10.1B | 46.00%6.62B |
Gross dividend payment | ||||||||||
Basic earnings per share | 59.96%172.66 | 68.01%544.95 | 103.03%154.22 | 46.29%144.64 | 113.06%138.15 | 27.45%107.94 | 47.79%324.36 | 91.00%75.96 | 36.86%98.87 | 46.00%64.84 |
Diluted earnings per share | 59.96%172.66 | 68.01%544.95 | 103.01%154.2102 | 46.29%144.64 | 113.09%138.15 | 27.45%107.94 | 47.79%324.36 | 91.03%75.96 | 36.86%98.87 | 46.00%64.8304 |
Dividend per share | 0 | 88.89%170 | 120.00%110 | 0 | 50.00%60 | 0 | 0.00%90 | 0.00%50 | 0 | 0.00%40 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |